3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma, Follicular
1
Hemophilia A
1
Coagulation Protein Disorders
1
Blood Coagulation Disorders
1
Interventions
Cyclophosphamide
20
Rituximab
18
obinutuzumab
14
Lenalidomide
14
zanubrutinib
11
fludarabine
10
Bendamustine Hydrochloride
10
Prednisone
8
Magnetic Resonance Spectroscopy
8
Vincristine
7
Doxorubicin
7
Specimen Handling
6
fludarabine phosphate
5
Radiotherapy
4
Biopsy
4
axicabtagene ciloleucel
3
Whole-Body Irradiation
3
tisagenlecleucel
2
polatuzumab vedotin
2
pirtobrutinib
2
loncastuximab tesirine
2
Therapeutics
2
Prednisolone
2
Positron Emission Tomography Computed Tomography
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma, Follicular
×
BIVV001
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled